Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
96 stocks in the UK match these filters · market cap, largest first. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| AZN.L | AstraZeneca PLC | Healthcare | $264.05B | 12,110.00 GBP | −23.02% | −6.41% |
| AZN.ST | AstraZeneca PLC | Healthcare | $263.97B | 1,568.00 SEK | −18.57% | −6.12% |
| AZN | AstraZeneca PLC | Healthcare | $263.12B | $169.66 | −20.24% | +0.01% |
| A1ZN34.SA | AstraZeneca PLC | Healthcare | $260.90B | 144.34 BRL | −24.19% | +0.85% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| GS71.DE | GSK plc | Healthcare | $104.54B | 22.16 EUR | −15.23% | −6.46% |
| G1SK34.SA | GSK plc | Healthcare | $104.53B | 53.80 BRL | −14.93% | +4.47% |
| GSK | GSK plc | Healthcare | $104.29B | $52.07 | −15.61% | +0.17% |
| GSK.L | GSK plc | Healthcare | $104.16B | 1,890.50 GBP | −17.16% | −6.83% |
| HLN | Haleon plc | Healthcare | $44.77B | $10.18 | −9.75% | +2.41% |
| H6D0.DE | Haleon plc | Healthcare | $44.53B | 4.34 EUR | −9.18% | −3.10% |
| HLN.L | Haleon plc | Healthcare | $44.36B | 369.80 GBP | −11.13% | −2.91% |
| ROIV | Roivant Sciences Ltd. | Healthcare | $26.26B | $36.47 | −3.95% | +5.04% |
| S1NN34.SA | Smith & Nephew plc | Healthcare | $12.87B | 31.62 BRL | −22.65% | 0.00% |
| SNN | Smith & Nephew plc | Healthcare | $12.23B | $29.22 | −24.67% | −6.11% |
| SN.L | Smith & Nephew plc | Healthcare | $12.20B | 1,082.00 GBP | −24.94% | −9.83% |
| CNTA | Centessa Pharmaceuticals plc | Healthcare | $6.27B | $40.50 | −0.15% | 0.00% |
| KNSA | Kiniksa Pharmaceuticals International, plc | Healthcare | $6.17B | $80.20 | −3.30% | +26.23% |
| CTEC.L | Convatec Group PLC | Healthcare | $6.06B | 228.00 GBP | −12.07% | −0.09% |
| HIK.L | Hikma Pharmaceuticals PLC | Healthcare | $4.63B | 1,633.00 GBP | −12.44% | +1.24% |
| LIVN | LivaNova PLC | Healthcare | $4.37B | $79.41 | −7.40% | −1.45% |
| ONT.L | Oxford Nanopore Technologies plc | Healthcare | $2.44B | 166.70 GBP | −21.29% | +49.78% |
| GNS.L | Genus plc | Healthcare | $2.08B | 2,288.00 GBP | −29.14% | +3.16% |
| CMPS | COMPASS Pathways plc | Healthcare | $2.06B | $14.88 | −3.38% | +32.03% |
| IMCR | Immunocore Holdings plc | Healthcare | $1.93B | $37.40 | −8.14% | +10.75% |
| SPI.L | Spire Healthcare Group plc | Healthcare | $1.30B | 234.50 GBP | −8.58% | +0.43% |
| CVSG.L | CVS Group plc | Healthcare | $1.20B | 1,292.00 GBP | −21.60% | +2.95% |
| OXB.L | Oxford Biomedica plc | Healthcare | $850.70M | 509.00 GBP | −47.09% | −8.45% |
| SLN | Silence Therapeutics plc | Healthcare | $849.65M | $13.67 | −22.22% | +13.26% |
| AMS.L | Advanced Medical Solutions Group plc | Healthcare | $835.93M | 282.00 GBP | −0.88% | +0.71% |
| AUTL | Autolus Therapeutics plc | Healthcare | $649.44M | $2.44 | −5.43% | +67.12% |
| CRW.L | Craneware plc | Healthcare | $594.31M | 1,296.00 GBP | −50.98% | +6.40% |
| AGY.L | Allergy Therapeutics plc | Healthcare | $483.53M | 5.60 GBP | −53.72% | +4.09% |
| AVCT.L | Avacta Group Plc | Healthcare | $444.39M | 68.80 GBP | −25.22% | +0.44% |
| NIOX.L | NIOX Group Plc | Healthcare | $382.51M | 68.00 GBP | −12.37% | +11.48% |
| OPT.L | Optima Health plc | Healthcare | $357.00M | 238.00 GBP | −7.03% | +3.70% |
| ANCR.L | Animalcare Group PLC | Healthcare | $315.65M | 335.00 GBP | −1.47% | +0.45% |
| BCYC | Bicycle Therapeutics plc | Healthcare | $306.47M | $4.39 | −52.07% | +11.14% |
| TSTL.L | Tristel plc | Healthcare | $278.82M | 427.50 GBP | −5.00% | +1.79% |
| DXRX.L | Diaceutics PLC | Healthcare | $165.73M | 139.50 GBP | −22.50% | +10.28% |
| EKF.L | EKF Diagnostics Holdings plc | Healthcare | $144.58M | 25.40 GBP | −20.63% | −3.42% |
| TLSA | Tiziana Life Sciences Ltd | Healthcare | $141.26M | $1.15 | −51.06% | +26.37% |
| SCLP.L | Scancell Holdings plc | Healthcare | $137.37M | 9.80 GBP | −66.78% | −1.51% |
| BVXP.L | Bioventix PLC | Healthcare | $124.78M | 1,750.00 GBP | −31.37% | +15.89% |
| 4BB.L | 4basebio PLC | Healthcare | $99.32M | 470.00 GBP | −48.91% | −10.48% |
| 88Q.DE | 4basebio PLC | Healthcare | $96.74M | 5.25 EUR | −49.52% | +5.00% |
| EAH.L | ECO Animal Health Group plc | Healthcare | $90.13M | 101.00 GBP | −13.60% | +3.59% |
| CREO.L | Creo Medical Group PLC | Healthcare | $85.36M | 12.88 GBP | −30.41% | −6.36% |
| POLB.L | Poolbeg Pharma PLC | Healthcare | $82.75M | 8.50 GBP | −7.61% | +38.21% |
| OKYO | OKYO Pharma Limited | Healthcare | $81.87M | $1.56 | −51.25% | −4.88% |
| KOO.L | Kooth plc | Healthcare | $72.99M | 147.50 GBP | −22.37% | −6.05% |
| STX.L | Shield Therapeutics plc | Healthcare | $70.81M | 4.70 GBP | −62.40% | −18.97% |
| SAR.L | Sareum Holdings plc | Healthcare | $70.74M | 29.00 GBP | −3.33% | +31.82% |
| HVO.L | hVIVO plc | Healthcare | $61.06M | 6.54 GBP | −40.55% | −7.89% |
| COIL.L | Coiled Therapeutics plc | Healthcare | $55.33M | 9.50 GBP | −68.33% | −5.00% |
| OHGR.L | One Health Group Plc | Healthcare | $54.00M | 292.50 GBP | −2.50% | +15.16% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | Healthcare | $53.78M | 580.00 GBP | −67.78% | −17.08% |
| MREO | Mereo BioPharma Group plc | Healthcare | $44.97M | $0.28 | −88.12% | −6.75% |
| MPAL.L | MEDPAL AI PLC ORD 0.02P | Healthcare | $39.82M | 3.90 GBP | −71.11% | +26.83% |
| ABDX.L | Abingdon Health Plc | Healthcare | $37.08M | 11.00 GBP | −15.38% | +11.68% |
| PXS.L | Provexis plc | Healthcare | $34.89M | 1.13 GBP | −27.42% | −3.85% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.